Summary & Overview
HCPCS C9737: Laparoscopic Esophageal Sphincter Augmentation
HCPCS Level II code C9737 denotes a laparoscopic surgical procedure for esophageal sphincter augmentation using an implantable device (for example, a magnetic band). The code identifies a minimally invasive intervention intended to reinforce the lower esophageal sphincter to treat gastroesophageal reflux disease. Nationally, device-based antireflux procedures are of growing relevance because of evolving clinical guidelines, device approvals, and payer coverage variability.
Key payers considered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context for device-based sphincter augmentation, typical sites of service and procedural classification, and what to expect in payer coverage environments. The publication also summarizes available national benchmarks where provided, recent policy or coding updates related to device implants, and billing considerations tied to laparoscopic surgical services.
This piece is intended to orient clinicians, billing professionals, and policy analysts to the clinical and administrative implications of HCPCS Level II code C9737, highlighting areas where payers differ and where further documentation or prior authorization may be relevant.
Billing Code Overview
HCPCS Level II code C9737 describes laparoscopy, surgical, esophageal sphincter augmentation with device (e.g., magnetic band). This procedure uses minimally invasive laparoscopic techniques to place an implantable device intended to augment the lower esophageal sphincter and reduce gastroesophageal reflux.
-
Service type: Surgical, laparoscopic implant procedure
-
Typical site of service: Ambulatory surgery center or hospital operating room
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is a 35–65-year-old adult with medically refractory gastroesophageal reflux disease (GERD) characterized by chronic heartburn, regurgitation, and esophageal acid exposure despite optimized proton pump inhibitor therapy and lifestyle modification. The patient often has documented pathologic acid reflux on pH testing, a hiatal hernia that is small to moderate or corrected at the time of surgery, and persistent symptoms affecting quality of life. Referral to an experienced foregut or minimally invasive surgeon occurs after multidisciplinary evaluation including upper endoscopy, esophageal manometry, and ambulatory pH testing. The clinical workflow includes preoperative evaluation (history, physical, anesthesia assessment, and necessary imaging), informed consent discussing risks and benefits of esophageal sphincter augmentation with a magnetic augmentation device (e.g., magnetic band), laparoscopic placement of the device around the gastroesophageal junction, intraoperative assessment of device position and hiatal repair as needed, postoperative monitoring for pain, dysphagia, or complications, short inpatient observation or same-day discharge depending on institutional practice, and follow-up with reflux symptom assessment and objective testing as indicated.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work required to perform C9737 is substantially greater than typically required (document rationale). |